# A Study of K-645 in the Treatment of Multiple Migraine Attacks

> **NCT07116499** · PHASE2 · TERMINATED · sponsor: **Kallyope Inc.** · enrollment: 134 (actual)

## Conditions studied

- Acute Migraine

## Interventions

- **DRUG:** Placebo
- **DRUG:** K-645 dose level 1
- **DRUG:** K-645 dose level 2

## Key facts

- **NCT ID:** NCT07116499
- **Lead sponsor:** Kallyope Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-08-12
- **Primary completion:** 2025-11-07
- **Final completion:** 2025-11-07
- **Target enrollment:** 134 (ACTUAL)
- **Why stopped:** Study stopped for futility based on an interim analysis of efficacy.
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116499, "A Study of K-645 in the Treatment of Multiple Migraine Attacks". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07116499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*